FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003283180> ?p ?o ?g. }

• W2003283180 endingPage "161" @default.
• W2003283180 startingPage "151" @default.
• W2003283180 abstract "Acrylamide is an important chemical used in the synthesis of polyacrylamides, which have a wide variety of industrial applications. The principal toxic effect of acrylamide, both in animals and in humans, is neurotoxicity. Peripheral nervous system effects are most prominent, but central nervous system effects have also been reported. Acrylamide is metabolized to the epoxide glycidamide, whose adducts to hemoglobin and to DNA have been identified in animals and humans. This metabolite may be involved in the reproductive and carcinogenic effects of acrylamide. In the present study we investigated whether glycidamide would exert neurotoxic effects similar to those caused by its parent compound. Male rats were injected i.p. with acrylamide (25 or 50 mg/kg) or glycidamide (50 or 100 mg/kg) daily for 8 days. Reduced weight gain was evident in animals exposed to glycidamide or to the higher dose of acrylamide. Both compounds induced lethargy and ataxia, but the posture of glycidamide-treated rats differed from that of animals treated with acrylamide. At the high doses, both compounds significantly affected rats' behavior in the rotarod test; on the other hand, only acrylamide was effective in the hindlimb splay test. Acrylamide inhibited activity of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in sciatic and tibial nerves, as well as in brain. Glycidamide inhibited GAPDH activity only in brain and activity of creatine kinase in both peripheral and central tissues. Acrylamide also caused profound urinary retention and distended bladders, while the effects of glycidamide were minimal. Morphological abnormalities were seen in sciatic nerves and dorsal root ganglion cells of rats treated with acrylamide (50 mg/kg × 12), but not in rats exposed to glycidamide (100 mg/kg × 11). These results indicate that the toxicities of acrylamide and glycidamide differ and suggest that acrylamide itself may be primarily responsible for its peripheral neurotoxicity." @default.
• W2003283180 created "2016-06-24" @default.
• W2003283180 creator A5014060243 @default.
• W2003283180 creator A5036990204 @default.
• W2003283180 creator A5077675687 @default.
• W2003283180 creator A5080855594 @default.
• W2003283180 date "1995-04-12" @default.
• W2003283180 modified "2023-09-23" @default.
• W2003283180 title "Evaluation of the neurotoxicity of glycidamide, an epoxide metabolite of acrylamide: behavioral, neurochemical and morphological studies" @default.
• W2003283180 cites W189590033 @default.
• W2003283180 cites W1968637118 @default.
• W2003283180 cites W1968763463 @default.
• W2003283180 cites W1969330915 @default.
• W2003283180 cites W1974774359 @default.
• W2003283180 cites W1980655248 @default.
• W2003283180 cites W1984526404 @default.
• W2003283180 cites W1988640129 @default.
• W2003283180 cites W1991635672 @default.
• W2003283180 cites W2005398690 @default.
• W2003283180 cites W2007483551 @default.
• W2003283180 cites W2007531409 @default.
• W2003283180 cites W2010535608 @default.
• W2003283180 cites W2015769650 @default.
• W2003283180 cites W2020847301 @default.
• W2003283180 cites W2022525968 @default.
• W2003283180 cites W2023474291 @default.
• W2003283180 cites W2027312449 @default.
• W2003283180 cites W2033298355 @default.
• W2003283180 cites W2034303749 @default.
• W2003283180 cites W2046248375 @default.
• W2003283180 cites W2064568339 @default.
• W2003283180 cites W2082007696 @default.
• W2003283180 cites W2092238408 @default.
• W2003283180 cites W2109914916 @default.
• W2003283180 cites W2113708127 @default.
• W2003283180 cites W2131377624 @default.
• W2003283180 cites W2148065883 @default.
• W2003283180 cites W2165240820 @default.
• W2003283180 cites W2167754023 @default.
• W2003283180 cites W2168893957 @default.
• W2003283180 cites W2248087544 @default.
• W2003283180 cites W2274171631 @default.
• W2003283180 cites W2317782901 @default.
• W2003283180 cites W2327026770 @default.
• W2003283180 cites W2330436374 @default.
• W2003283180 cites W2402209330 @default.
• W2003283180 cites W2407064831 @default.
• W2003283180 cites W2183956076 @default.
• W2003283180 doi "https://doi.org/10.1016/0300-483x(94)02986-5" @default.
• W2003283180 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7740544" @default.
• W2003283180 hasPublicationYear "1995" @default.
• W2003283180 type Work @default.
• W2003283180 sameAs 2003283180 @default.
• W2003283180 citedByCount "34" @default.
• W2003283180 countsByYear W20032831802012 @default.
• W2003283180 countsByYear W20032831802014 @default.
• W2003283180 countsByYear W20032831802015 @default.
• W2003283180 countsByYear W20032831802017 @default.
• W2003283180 countsByYear W20032831802018 @default.
• W2003283180 countsByYear W20032831802019 @default.
• W2003283180 countsByYear W20032831802021 @default.
• W2003283180 countsByYear W20032831802023 @default.
• W2003283180 crossrefType "journal-article" @default.
• W2003283180 hasAuthorship W2003283180A5014060243 @default.
• W2003283180 hasAuthorship W2003283180A5036990204 @default.
• W2003283180 hasAuthorship W2003283180A5077675687 @default.
• W2003283180 hasAuthorship W2003283180A5080855594 @default.
• W2003283180 hasConcept C134018914 @default.
• W2003283180 hasConcept C15920480 @default.
• W2003283180 hasConcept C178790620 @default.
• W2003283180 hasConcept C185592680 @default.
• W2003283180 hasConcept C2777477808 @default.
• W2003283180 hasConcept C2779402116 @default.
• W2003283180 hasConcept C2779491297 @default.
• W2003283180 hasConcept C29730261 @default.
• W2003283180 hasConcept C521977710 @default.
• W2003283180 hasConcept C55493867 @default.
• W2003283180 hasConcept C86803240 @default.
• W2003283180 hasConcept C98274493 @default.
• W2003283180 hasConceptScore W2003283180C134018914 @default.
• W2003283180 hasConceptScore W2003283180C15920480 @default.
• W2003283180 hasConceptScore W2003283180C178790620 @default.
• W2003283180 hasConceptScore W2003283180C185592680 @default.
• W2003283180 hasConceptScore W2003283180C2777477808 @default.
• W2003283180 hasConceptScore W2003283180C2779402116 @default.
• W2003283180 hasConceptScore W2003283180C2779491297 @default.
• W2003283180 hasConceptScore W2003283180C29730261 @default.
• W2003283180 hasConceptScore W2003283180C521977710 @default.
• W2003283180 hasConceptScore W2003283180C55493867 @default.
• W2003283180 hasConceptScore W2003283180C86803240 @default.
• W2003283180 hasConceptScore W2003283180C98274493 @default.
• W2003283180 hasIssue "1-3" @default.
• W2003283180 hasLocation W20032831801 @default.
• W2003283180 hasLocation W20032831802 @default.
• W2003283180 hasOpenAccess W2003283180 @default.
• W2003283180 hasPrimaryLocation W20032831801 @default.
• W2003283180 hasRelatedWork W2023487034 @default.
• W2003283180 hasRelatedWork W2080815447 @default.

• next